about
Treating and preventing acute exacerbations of COPDLong-acting inhaled beta 2-agonists for stable COPD.alpha1-Antitrypsin deficiency . 5: intravenous augmentation therapy: current understandingCharacteristics of Alpha-1 Antitrypsin-Deficient Individuals in the Long-term Oxygen Treatment Trial and Comparison with Other Subjects with Chronic Obstructive Pulmonary DiseasePolysomnographic determinants of nocturnal hypercapnia in patients with sleep apneaExpiratory Time Constant and Sleep Apnea Severity in the Overlap Syndrome.Long-term continuous positive airway pressure therapy normalizes high exhaled nitric oxide levels in obstructive sleep apnea.Challenges in cardiac risk assessment in bariatric surgery patients.Determinants of long-term mortality after prolonged mechanical ventilation.Detection of alpha-1 antitrypsin deficiency: a review.Determinants of hypercapnia in obese patients with obstructive sleep apnea: a systematic review and metaanalysis of cohort studies.Mechanisms of exercise limitation and pulmonary rehabilitation for patients with neuromuscular disease.Noninvasive positive pressure ventilation: Increasing use in acute care.Noninvasive positive pressure ventilation for stable outpatients: CPAP and beyond.Sleep quality, depression, and quality of life in patients with pulmonary hypertension.A review of α1-antitrypsin deficiency.Hyperinflation on chest radiograph as a marker of low adherence to positive airway pressure therapy in the overlap syndrome.Chronic obstructive pulmonary disease: an update for the primary physician.Sleep-disordered Breathing in Neuromuscular Disease.Neuromuscular weakness in chronic obstructive pulmonary disease: chest wall, diaphragm, and peripheral muscle contributions.Sleep-Disordered Breathing in Neuromuscular Disease: Diagnostic and Therapeutic Challenges.Determinants of Wake Pco2 and Increases in Wake Pco2 over Time in Patients with Obstructive Sleep Apnea.Dynamic pharyngoscopy in predicting outcome of uvulopalatopharyngoplasty for moderate and severe obstructive sleep apnea.A 26-Year-Old Woman With Systemic Lupus Erythematosus Presenting With Orthopnea and Restrictive Lung Impairment.Limitations and promise in the diagnosis and treatment of obstructive sleep apnoea.Postoperative Complications in Patients With Unrecognized Obesity Hypoventilation Syndrome Undergoing Elective Noncardiac Surgery.Effect of acute aminophylline administration on diaphragm function in high cervical tetraplegia: a case report.Cough Augmentation in a Patient with Neuromuscular Disease.Determinants of time-to-weaning in a specialized respiratory care unit.Impact of a Post-Discharge Integrated Disease Management Program on COPD Hospital Readmissions.Modeling of Lung Function Recovery in Neuralgic Amyotrophy With Diaphragm Impairment.Posthypoxic ventilatory decline during NREM sleep: influence of sleep apnea.Effect of noninvasive positive-pressure ventilation on survival in amyotrophic lateral sclerosis.Sleep, respiration and ALS.Acute exacerbations of chronic bronchitis.Sudden Onset of Dyspnea Preceded by Shoulder and Arm Pain.Objective measures of the efficacy of noninvasive positive-pressure ventilation in amyotrophic lateral sclerosis.Patient-Ventilator Asynchronies during PolysomnographyPulmonary infarction due to pulmonary embolismHypoplastic trachea in Down's syndrome
P50
Q26750928-362F155A-1BAC-4950-BEED-10AD14DBF817Q35201031-A4E7A983-4CB2-4B2F-9143-7CBBD846595DQ35536847-A78C6E5D-AF38-4B7A-9288-06DE05714C49Q36490121-ED1E5705-44A7-4265-B9C2-4C69F52C9600Q36627736-7D246EAC-7E6E-4567-A4CA-6034FC22B1CBQ36637768-014038B2-7B8E-4623-900A-1ABD2881DE00Q36860372-15BE6801-3FE2-4F88-A7C9-E05A6A802DBAQ37027363-EFF4C8DE-0C69-4BE7-8B2A-5B7D0901780EQ37230990-2D86BB99-C648-4ABE-B637-0111B22CDF77Q37327295-1DA2BAFA-5875-428F-B616-83C081F76674Q37536511-5F8AE1F2-01D7-4085-A193-A6F86640253AQ37621814-9216DD6C-8BDA-493E-AD23-762111AD27CAQ37741627-4BD93758-6140-40D1-A590-F3716AC2170AQ37796483-D1F93037-A56F-4EAF-AEEC-C18927E02412Q37822694-8D8C8CDF-6169-4CC3-9E9B-42FEE7C7DD38Q37940937-F3FB6930-43EE-479A-80BA-15073AD935A7Q38172084-A19BECF7-1BAC-48E0-9A11-6F64D196DA46Q38217206-9D829CC5-299A-45EC-83CA-BD792CFA6AD4Q38365859-9EC05373-C959-4EA0-A316-C9374DFBC3D0Q39082779-45AC0BFE-341E-45E3-B210-A35545DF73F6Q39217430-21086275-6FE3-4229-8018-C919DEF2D691Q40242629-55D1A0BB-AA69-4212-B4A0-AD9C0DD31A6FQ40499846-EF78C508-C71A-470C-98F1-3F91CC7D5A46Q40836409-ED6FC9D2-1441-4267-AD74-47AB6062CCCFQ41474815-D13E57E3-6F8F-40AE-A07F-5BD771F272FCQ41724853-87B8295D-09FB-49D6-A6BD-90CC83454A12Q45261446-1567E2D4-3E2C-48E7-8351-BE82606D4AB5Q46083508-318BCF8E-2CBE-44A7-A79E-C197DDDD6BC9Q46817024-A4E6736D-EF91-4BF7-BE1D-88A8A7C8A25FQ47814539-A747E3A8-EEA1-4A7F-A97B-93F3691BBE36Q47836652-275B951C-CB4F-47DB-99C0-FD4962C0AA55Q48013470-D0C7C048-4E68-498D-969B-2724B81AA099Q48622354-14043DEC-7662-4B3D-A126-611C2DA20CF3Q48758946-AC98A6A7-09B4-4BE6-B045-5C5B02FCE9CBQ49908734-30E2C3AF-F003-4ACC-9AF8-F1FEA313A5C5Q51455005-D5F29C71-4C6C-4682-B7B1-EAB93FE0AC02Q53486028-2122BAF5-2F6D-4398-B90E-0534B4AAFBE0Q57051732-EF0AEB0F-FFD0-45FF-84BE-9E40E6C59955Q58547873-DEF82B35-A65E-424C-8E32-B638C45B0C50Q70530094-0843FA0E-B3AB-4239-8B36-7A714D431EC3
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Loutfi S Aboussouan
@nl
Loutfi S Aboussouan
@sl
Loutfi S. Aboussouan
@en
Loutfi S. Aboussouan
@es
type
label
Loutfi S Aboussouan
@nl
Loutfi S Aboussouan
@sl
Loutfi S. Aboussouan
@en
Loutfi S. Aboussouan
@es
prefLabel
Loutfi S Aboussouan
@nl
Loutfi S Aboussouan
@sl
Loutfi S. Aboussouan
@en
Loutfi S. Aboussouan
@es
P106
P108
P1153
6604072878
P31
P496
0000-0003-2716-0904